Aussie Trials Show Drug Combo Effective Against Breast Cancer
This article was originally published in PharmAsia News
Phase III trials involving Australian participants taking a popular chemotherapy drug along with the cancer-fighting Avastin (bevacizumab) showed the combination effective against advanced breast cancer. The Sanofi-Aventis drug Taxotere (docetaxel) is widely used in Australia for chemotherapy treatment. Researchers reported at an international cancer conference that trials, including those conducted in Australia, showed combining Taxotere with Genentech's Avastin slowed the progression of HER2-negative advanced breast cancer. (Click here for more
You may also be interested in...
The company has no development programs left in its R&D pipeline and will focus entirely on the commercialization of IBS drug Linzess while seeking late-stage assets from external sources.
The documents issued by the US agency on 29 September set slightly different accuracy standards, reflecting the increased fragility of hospital patients.
The US FDA commissioner published a blog post commending and highlighting the work device center staff have done during the pandemic to speed tests and devices to market to save lives.